Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Johnson and Johnson develops Caps system

Johnson and Johnson develops Caps system

28th March 2008

Ethicon Endo-Surgery, a Johnson & Johnson company, has announced the development of a computer-assisted personalised sedation (Caps) system for the administration of minimal to moderate propofol sedation.

The system is designed for use by teams of physicians for use in patients undergoing screening and diagnostic procedures for upper gastrointestinal tract disorders and colorectal cancers.

Ethicon Endo-Surgery has this week announced that the Sedasys system has been submitted for premarket approval to the US Food and Drug Administration.

The Sedasys system administers Diprivan (propofol) to patients, which gives both a rapid onset and quick recovery.

“The premarketing approval submission includes results from a multi-centre prospective, randomised, controlled trial of 1,000 patients that compared the safety and effectiveness of the Sedasys System to the current standard of care for sedation in routine endoscopic procedures – physician-administered benzodiazepine and opioids,” the company said.

It added that the pivotal clinical trial for the system was conducted from March 2007 to October 2007 at eight sites across the US.

In November 2007, Johnson & Johnson announced the creation of three new units with the aim of increasing growth and focusing on business units outside of its traditional areas.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.